Please use this identifier to cite or link to this item: http://docs.prosentient.com.au/prosentientjspui/handle/1/10680
Title: Australian bat lyssavirus: implications for public health.
Authors: Francis, Joshua R
McCall, Bradley J
Hutchinson, Penny
Powell, Jodie
Vaska, Vikram L
Nourse, Clare
Affiliation: Department of Paediatrics, Royal Darwin Hospital, Darwin, NT, Australia. josh.francis@nt.gov.au..
Metro South Public Health Unit, Queensland Health, Brisbane, QLD, Australia..
Darling Downs Public Health Unit, Queensland Health, Toowoomba, QLD, Australia..
Mater Health Services, Brisbane, QLD, Australia..
Mater Pathology, Brisbane, QLD, Australia..
Mater Health Services, Brisbane, QLD, Australia..
Issue Date: 11-Dec-2014
Citation: The Medical journal of Australia 2014-12-11; 201(11): 647-9
Abstract: Australian bat lyssavirus (ABLV) infection in humans is rare but fatal, with no proven effective therapy. ABLV infection can be prevented by administration of a post-exposure prophylaxis regimen of human rabies immunoglobulin and rabies vaccine. All Australian bats (flying foxes and microbats) should be considered to be carrying ABLV unless proven otherwise. Any bat-related injury (bite, scratch or mucosal exposure to bat saliva or neural tissue) should be notified immediately to the relevant public health unit - no matter how small the injury or how long ago it occurred. Human-to-human transmission of ABLV has not been reported but is theoretically possible. Standard infection control precautions should be employed when managing patients with suspected or confirmed ABLV infection.
URI: http://docs.prosentient.com.au/prosentientjspui/handle/1/10680
Type: Journal Article
Review
Subjects: Animals
Australia
Bites and Stings
Chiroptera
Disease Vectors
Humans
Public Health
Rhabdoviridae Infections
Lyssavirus
Appears in Collections:NT Health digital library

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.